$70

Peptides
Vilon
Vilon (Lys-Glu) research peptide, a dipeptide from russian peptide bioregulator research. Supplied as a lyophilised powder in 20mg vials.
Supplied as lyophilised powder in a 20mg specification. Storage: -20°C · Keep dry, avoid light. Dispatched from Sydney, Australia-wide.
Product information
About Vilon
Lys-Glu (KE)
Research background as published in the scientific literature. Supplied for in-vitro laboratory research only; nothing here is a claim about use in humans or animals.
Vilon is a synthetic dipeptide with the sequence Lys-Glu (KE). It is the shortest of the peptide bioregulators developed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology, and was designed from the amino acid analysis of a thymus extract.
Vilon peptide has been studied mainly by that group, in immune cell cultures, tissue explants and animal models of ageing. The work is preclinical and largely published in Russian journals, and independent replication is limited.
Quantified Peptides supplies Vilon 20mg as a lyophilised research peptide in a sealed vial, dispatched from Sydney, Australia. It is a reference material for in-vitro research into short regulatory peptides.
- Type
- Synthetic dipeptide
- Sequence
- Lys-Glu
- Research Areas
- Immune cell models, thymus research, ageing biology
- Molecular Formula
- C11H21N3O5
- Molecular Weight
- 275.3 g/mol
- Research Area
- Immune and thymic cell biology
- Origin
- Russian peptide bioregulator research
- Research Models
- Cell culture, animal models
- 01Immune Cell ModelsVilon has been examined in cultures of lymphocytes and thymic cells, where researchers measured markers of cell proliferation and differentiation in the presence of the dipeptide.
- 02Chromatin and Gene ExpressionWork from the Khavinson group reports changes in chromatin structure and in the expression of selected genes in cultured cells from older donors exposed to Vilon.
- 03Ageing ResearchVilon was studied in long-term animal experiments on lifespan and spontaneous tumour incidence, published in the Russian-language literature in the early 2000s.
References
- 1Khavinson VKh, Anisimov VN. A synthetic dipeptide vilon (L-Lys-L-Glu) increases life span and inhibits development of spontaneous tumors in mice. Dokl Biol Sci. 2000;372:261–263.
- 2Khavinson VKh. Peptides and ageing. Neuro Endocrinol Lett. 2002;23 Suppl 3:11–144.
- 3PubMed: pubmed.ncbi.nlm.nih.gov/?term=vilon+peptide
Also in this range.
Compounds the supplier files alongside this one.


